UNION CITY, Calif.,
Nov. 4, 2016 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company
manufacturing point-of-care blood analysis instruments and
consumables for the medical and veterinary markets worldwide,
announced today that Ross Taylor,
chief financial officer, will present at the Stephens 2016 Fall
Investment Conference on Wednesday, November
9, 2016 at 11:00 a.m. ET. The
conference will be held at the Lotte New York Palace Hotel in
New York City.
Mr. Taylor will also participate in the 2016 Northcoast Research
Fall Management Forum on Thursday, November
10, 2016. The conference will be held at the
InterContinental New York Barclay in New
York City.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer
of portable blood analysis systems that are used in a broad range
of medical specialties in human or veterinary patient care to
provide clinicians with rapid blood constituent measurements. Our
mission is to improve the efficiency of care delivery to and the
quality of life of patients in the medical and veterinary markets.
We provide leading edge technology and tools that support best
medical practices, enabling physicians and veterinarians to respond
to the health needs of their clients at the point of care while
operating economical and profitable practices. For more
information, visit http://www.abaxis.com.
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz
& Robert
Blum
|
|
ABAXIS,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abaxis-inc-to-present-at-the-stephens-2016-fall-investment-conference-and-participate-in-the-northcoast-research-fall-management-forum-300357488.html
SOURCE Abaxis, Inc.